Does the media refer more to DH or AMWL?

In the previous week, Definitive Healthcare had 2 more articles in the media than American Well. MarketBeat recorded 4 mentions for Definitive Healthcare and 2 mentions for American Well. American Well's average media sentiment score of 1.08 beat Definitive Healthcare's score of 0.26 indicating that American Well is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Definitive Healthcare 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral American Well 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to DH or OPRX?

In the previous week, Definitive Healthcare had 3 more articles in the media than OptimizeRx. MarketBeat recorded 4 mentions for Definitive Healthcare and 1 mentions for OptimizeRx. Definitive Healthcare's average media sentiment score of 0.26 beat OptimizeRx's score of 0.00 indicating that Definitive Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Definitive Healthcare 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor CCLD or DH?

In the previous week, Definitive Healthcare had 2 more articles in the media than CareCloud. MarketBeat recorded 4 mentions for Definitive Healthcare and 2 mentions for CareCloud. CareCloud's average media sentiment score of 0.33 beat Definitive Healthcare's score of 0.26 indicating that CareCloud is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareCloud 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Definitive Healthcare 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer HIT or DH?

In the previous week, Definitive Healthcare had 1 more articles in the media than Health In Tech. MarketBeat recorded 4 mentions for Definitive Healthcare and 3 mentions for Health In Tech. Health In Tech's average media sentiment score of 0.92 beat Definitive Healthcare's score of 0.26 indicating that Health In Tech is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health In Tech 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Definitive Healthcare 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Definitive Healthcare (DH) Competitors

$0.72 +0.01 (+0.95%)

Closing price 08/24/2026 04:00 PM Eastern

Extended Trading

$0.74 +0.02 (+2.09%)

As of 04:01 AM Eastern

Compare

DH vs. AMWL, OPRX, HCAT, CCLD, and HIT

Should you buy Definitive Healthcare stock or one of its competitors? Definitive Healthcare's main competitors and comparable companies include American Well (AMWL), OptimizeRx (OPRX), Health Catalyst (HCAT), CareCloud (CCLD), and Health In Tech (HIT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Definitive Healthcare compare to American Well?

Definitive Healthcare (NASDAQ:DH) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

In the previous week, Definitive Healthcare had 2 more articles in the media than American Well. MarketBeat recorded 4 mentions for Definitive Healthcare and 2 mentions for American Well. American Well's average media sentiment score of 1.08 beat Definitive Healthcare's score of 0.26 indicating that American Well is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Definitive Healthcare	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
American Well	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

American Well has a net margin of -35.75% compared to Definitive Healthcare's net margin of -72.28%. Definitive Healthcare's return on equity of 3.55% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-72.28%	3.55%	1.63%
American Well	-35.75%	-30.12%	-22.30%

Definitive Healthcare has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market. Comparatively, American Well has a beta of 1.68, indicating that its share price is 68% more volatile than the broader market.

Definitive Healthcare currently has a consensus price target of $1.47, indicating a potential upside of 104.11%. American Well has a consensus price target of $9.50, indicating a potential downside of 20.26%. Given Definitive Healthcare's higher possible upside, equities analysts clearly believe Definitive Healthcare is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.89
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 17.1% of Definitive Healthcare shares are owned by company insiders. Comparatively, 12.8% of American Well shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

American Well has higher revenue and earnings than Definitive Healthcare. American Well is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$232.70M	0.33	-$138.93M	-$1.60	N/A
American Well	$249.32M	0.79	-$95.70M	-$4.77	N/A

Summary

Definitive Healthcare beats American Well on 9 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to OptimizeRx?

Definitive Healthcare (NASDAQ:DH) and OptimizeRx (NASDAQ:OPRX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, risk, valuation, media sentiment, institutional ownership, earnings and profitability.

OptimizeRx has a net margin of 4.66% compared to Definitive Healthcare's net margin of -72.28%. OptimizeRx's return on equity of 9.44% beat Definitive Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Definitive Healthcare	-72.28%	3.55%	1.63%
OptimizeRx	4.66%	9.44%	7.11%

OptimizeRx has lower revenue, but higher earnings than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Definitive Healthcare	$232.70M	0.33	-$138.93M	-$1.60	N/A
OptimizeRx	$109.43M	1.32	$5.13M	$0.23	33.26

Definitive Healthcare has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market. Comparatively, OptimizeRx has a beta of 1.08, meaning that its share price is 8% more volatile than the broader market.

98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 17.1% of Definitive Healthcare shares are held by company insiders. Comparatively, 7.5% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Definitive Healthcare currently has a consensus target price of $1.47, suggesting a potential upside of 104.11%. OptimizeRx has a consensus target price of $11.43, suggesting a potential upside of 49.39%. Given Definitive Healthcare's higher probable upside, research analysts clearly believe Definitive Healthcare is more favorable than OptimizeRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Definitive Healthcare	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.89
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

In the previous week, Definitive Healthcare had 3 more articles in the media than OptimizeRx. MarketBeat recorded 4 mentions for Definitive Healthcare and 1 mentions for OptimizeRx. Definitive Healthcare's average media sentiment score of 0.26 beat OptimizeRx's score of 0.00 indicating that Definitive Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Definitive Healthcare	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

OptimizeRx beats Definitive Healthcare on 9 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

Definitive Healthcare has a net margin of -72.28% compared to Health Catalyst's net margin of -90.61%. Definitive Healthcare's return on equity of 3.55% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-90.61%	-1.83%	-0.80%
Definitive Healthcare	-72.28%	3.55%	1.63%

Health Catalyst has a beta of 1.55, suggesting that its stock price is 55% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market.

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are held by institutional investors. 19.4% of Health Catalyst shares are held by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Health Catalyst currently has a consensus price target of $2.82, suggesting a potential upside of 77.53%. Definitive Healthcare has a consensus price target of $1.47, suggesting a potential upside of 104.11%. Given Definitive Healthcare's higher possible upside, analysts clearly believe Definitive Healthcare is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.15
Definitive Healthcare	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.89

Definitive Healthcare has lower revenue, but higher earnings than Health Catalyst. Definitive Healthcare is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.38	-$177.97M	-$3.68	N/A
Definitive Healthcare	$232.70M	0.33	-$138.93M	-$1.60	N/A

In the previous week, Definitive Healthcare had 4 more articles in the media than Health Catalyst. MarketBeat recorded 4 mentions for Definitive Healthcare and 0 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.59 beat Definitive Healthcare's score of 0.26 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Overall Sentiment
Health Catalyst	Positive
Definitive Healthcare	Neutral

Summary

Definitive Healthcare beats Health Catalyst on 9 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to CareCloud?

CareCloud (NASDAQ:CCLD) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 14.8% of CareCloud shares are owned by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

CareCloud has higher earnings, but lower revenue than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$128.64M	0.83	$10.80M	$0.07	35.71
Definitive Healthcare	$232.70M	0.33	-$138.93M	-$1.60	N/A

In the previous week, Definitive Healthcare had 2 more articles in the media than CareCloud. MarketBeat recorded 4 mentions for Definitive Healthcare and 2 mentions for CareCloud. CareCloud's average media sentiment score of 0.33 beat Definitive Healthcare's score of 0.26 indicating that CareCloud is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareCloud	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Definitive Healthcare	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CareCloud has a net margin of 6.21% compared to Definitive Healthcare's net margin of -72.28%. CareCloud's return on equity of 27.07% beat Definitive Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	6.21%	27.07%	14.56%
Definitive Healthcare	-72.28%	3.55%	1.63%

CareCloud currently has a consensus target price of $3.25, suggesting a potential upside of 30.00%. Definitive Healthcare has a consensus target price of $1.47, suggesting a potential upside of 104.11%. Given Definitive Healthcare's higher possible upside, analysts clearly believe Definitive Healthcare is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Definitive Healthcare	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.89

CareCloud has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.35, suggesting that its share price is 35% more volatile than the broader market.

Summary

CareCloud beats Definitive Healthcare on 11 of the 17 factors compared between the two stocks.

How does Definitive Healthcare compare to Health In Tech?

Health In Tech (NASDAQ:HIT) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Health In Tech has higher earnings, but lower revenue than Definitive Healthcare. Health In Tech is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83M	1.94	-$4.59M	-$0.07	N/A
Definitive Healthcare	$232.70M	0.33	-$138.93M	-$1.60	N/A

Health In Tech currently has a consensus target price of $3.50, suggesting a potential upside of 260.82%. Definitive Healthcare has a consensus target price of $1.47, suggesting a potential upside of 104.11%. Given Health In Tech's stronger consensus rating and higher probable upside, equities research analysts plainly believe Health In Tech is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Definitive Healthcare	3 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.89

In the previous week, Definitive Healthcare had 1 more articles in the media than Health In Tech. MarketBeat recorded 4 mentions for Definitive Healthcare and 3 mentions for Health In Tech. Health In Tech's average media sentiment score of 0.92 beat Definitive Healthcare's score of 0.26 indicating that Health In Tech is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health In Tech	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Definitive Healthcare	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Health In Tech has a beta of 2.82, indicating that its share price is 182% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market.

98.7% of Definitive Healthcare shares are held by institutional investors. 77.7% of Health In Tech shares are held by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Health In Tech has a net margin of 0.00% compared to Definitive Healthcare's net margin of -72.28%. Definitive Healthcare's return on equity of 3.55% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Definitive Healthcare	-72.28%	3.55%	1.63%

Summary

Health In Tech beats Definitive Healthcare on 10 of the 16 factors compared between the two stocks.

Get Definitive Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DH vs. The Competition

Export

Metric	Definitive Healthcare	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$76.23M	$1.72B	$7.36B	$12.81B
Dividend Yield	N/A	4.69%	2.54%	10.78%
P/E Ratio	-0.45	21.28	270.59	24.05
Price / Sales	0.33	78.65	643.38	104.95
Price / Cash	0.36	31.69	29.03	36.89
Price / Book	0.27	5.82	11.09	6.40
Net Income	-$138.93M	-$18.66M	$3.46B	$347.95M
7 Day Performance	9.23%	0.88%	1.73%	1.48%
1 Month Performance	5.55%	12.48%	7.34%	5.13%
1 Year Performance	-81.93%	-16.33%	26.13%	17.00%

Definitive Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DH Definitive Healthcare	2.5065 of 5 stars	$0.72 +1.0%	$1.47 +104.1%	-82.2%	$76.23M	$232.70M	N/A	970	Gap Down
AMWL American Well	2.9117 of 5 stars	$12.12 -1.8%	$9.50 -21.6%	+66.3%	$200.53M	$218.53M	N/A	1,040	Positive News
OPRX OptimizeRx	3.6887 of 5 stars	$8.38 -1.2%	$11.43 +36.4%	-55.7%	$157.25M	$98.65M	36.44	100
HCAT Health Catalyst	3.1539 of 5 stars	$1.71 +0.3%	$2.93 +72.0%	-51.5%	$128.31M	$292.25M	N/A	1,200
CCLD CareCloud	3.8389 of 5 stars	$2.62 +5.9%	$3.25 +24.3%	-11.7%	$111.11M	$120.50M	37.36	3,650

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DH) was last updated on 8/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Definitive Healthcare (DH) Competitors

DH vs. AMWL, OPRX, HCAT, CCLD, and HIT

How does Definitive Healthcare compare to American Well?

Summary

How does Definitive Healthcare compare to OptimizeRx?

Summary

How does Definitive Healthcare compare to Health Catalyst?

Summary

How does Definitive Healthcare compare to CareCloud?

Summary

How does Definitive Healthcare compare to Health In Tech?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Definitive Healthcare (DH) Competitors

DH vs. AMWL, OPRX, HCAT, CCLD, and HIT

How does Definitive Healthcare compare to American Well?

Does the media refer more to DH or AMWL?

Is DH or AMWL more profitable?

Which has more volatility & risk, DH or AMWL?

Do analysts rate DH or AMWL?

Do insiders and institutionals have more ownership in DH or AMWL?

Which has preferable valuation & earnings, DH or AMWL?

Summary

How does Definitive Healthcare compare to OptimizeRx?

Is DH or OPRX more profitable?

Which has better earnings & valuation, DH or OPRX?

Which has more risk & volatility, DH or OPRX?

Do institutionals & insiders hold more shares of DH or OPRX?

Do analysts prefer DH or OPRX?

Does the media refer more to DH or OPRX?

Summary

How does Definitive Healthcare compare to Health Catalyst?

Is HCAT or DH more profitable?

Which has more volatility & risk, HCAT or DH?

Do insiders & institutionals hold more shares of HCAT or DH?

Do analysts prefer HCAT or DH?

Which has stronger earnings and valuation, HCAT or DH?

Does the media favor HCAT or DH?

Summary

How does Definitive Healthcare compare to CareCloud?

Do insiders and institutionals hold more shares of CCLD or DH?

Which has stronger valuation & earnings, CCLD or DH?

Does the media favor CCLD or DH?

Is CCLD or DH more profitable?

Do analysts rate CCLD or DH?

Which has more volatility & risk, CCLD or DH?

Summary

How does Definitive Healthcare compare to Health In Tech?

Which has better valuation & earnings, HIT or DH?

Do analysts prefer HIT or DH?

Does the media prefer HIT or DH?

Which has more risk and volatility, HIT or DH?

Do institutionals and insiders hold more shares of HIT or DH?

Is HIT or DH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DH vs. The Competition

Definitive Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools